search
Back to results

Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon

Primary Purpose

Atrial Fibrillation

Status
Completed
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
HeartLight X3
Sponsored by
CardioFocus
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • paroxysmal atrial fibrillation failure of at least one AAD others

Exclusion Criteria:

  • overall good health as established by multiple criteria

Sites / Locations

  • Nemocnice Na Homolce

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

HeartLight X3

Arm Description

Pulmonary vein isolation using HeartLight X3

Outcomes

Primary Outcome Measures

Ablation time
Ablation time

Secondary Outcome Measures

Procedure time
Procedure time
PV Isolation
Percent of isolated pulmonary veins
PAE Rate
Primary Adverse Event rate
AF Free Rate
6- and 12-month chronic results

Full Information

First Posted
March 6, 2018
Last Updated
February 5, 2021
Sponsor
CardioFocus
search

1. Study Identification

Unique Protocol Identification Number
NCT03470636
Brief Title
Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon
Official Title
Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) With Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Atrial Fibrillation
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
February 15, 2018 (Actual)
Primary Completion Date
November 15, 2018 (Actual)
Study Completion Date
January 16, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
CardioFocus

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The objective of the study is to demonstrate the improved ablation and procedure times of the HeartLight X3 compared to the current HeartLight catheter in the treatment of atrial fibrillation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
HeartLight X3
Arm Type
Experimental
Arm Description
Pulmonary vein isolation using HeartLight X3
Intervention Type
Device
Intervention Name(s)
HeartLight X3
Intervention Description
Pulmonary vein isolation
Primary Outcome Measure Information:
Title
Ablation time
Description
Ablation time
Time Frame
Acute - at the end of the index procedure
Secondary Outcome Measure Information:
Title
Procedure time
Description
Procedure time
Time Frame
Acute - at the end of the index procedure
Title
PV Isolation
Description
Percent of isolated pulmonary veins
Time Frame
Acute - at the end of the index procedure
Title
PAE Rate
Description
Primary Adverse Event rate
Time Frame
30 Days
Title
AF Free Rate
Description
6- and 12-month chronic results
Time Frame
6 and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: paroxysmal atrial fibrillation failure of at least one AAD others Exclusion Criteria: overall good health as established by multiple criteria
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Burke T. Barrett
Organizational Affiliation
CardioFocus, Inc.
Official's Role
Study Director
Facility Information:
Facility Name
Nemocnice Na Homolce
City
Prague
Country
Czechia

12. IPD Sharing Statement

Citations:
PubMed Identifier
33570423
Citation
Schmidt B, Petru J, Chun KRJ, Sediva L, Bordignon S, Chen S, Neuzil P. Pivotal Study of a Novel Motor-Driven Endoscopic Ablation System. Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009544. doi: 10.1161/CIRCEP.120.009544. Epub 2021 Feb 11.
Results Reference
derived

Learn more about this trial

Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon

We'll reach out to this number within 24 hrs